Related Research Articles
Genentech, Inc., is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 50% of all vaccines manufactured in the world. With industry standards compliant mega production capabilities and large number of skilled domestic workforce, Indian exports meet the standards and requirements of highly regulated markets of USA, UK, European Union and Canada. According to the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, domestic pharmaceutical market turnover reached Rs 129,015 crore in 2018, growing 9.4 per cent year-on-year and exports revenue was US$17.28 billion in FY18 and US$19.14 billion in FY19.
Sigma Healthcare Limited is an Australian, ASX-listed company [ASX:SIG] with a focus on the pharmacy industry. In addition to its wholesale and distribution arms, Sigma Healthcare also owns Australian retail pharmacy brands: Amcal and Discount Drug Stores.
Thermo Fisher Scientific Inc. is an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).
Sons of Gwalia was a Western Australian mining company that mined gold, tantalum, spodumene, lithium and tin. It was Australia's third-largest gold producer and also controlled more than half the world's production of tantalum, before entering administration in August 2004 following a financial collapse.
John Andrew Henry Forrest, nicknamed Twiggy, is an Australian businessman. He is best known as the former CEO of Fortescue Metals Group (FMG), and has other interests in the mining industry and in cattle stations.
The King of the Hills Gold Mine, formerly the Tarmoola Gold Mine, is located 29 km north-west of Leonora, Western Australia. The mine was placed in care and maintenance from September 2004, when a pit wall failure forced its closure. It is owned by Saracen Mineral Holdings Limited.
Normandy Mining was an Australian mining company which predominantly mined gold. Normandy was, during much of the late 20th century, Australia's largest gold miner.
The Randalls Gold Mine is a gold mine, recently developed, located 36 km east-north-east of Kambalda, Western Australia, near Mount Monger Station.
Avoca Resources Limited was an Australian gold mining company, based in Perth, Western Australia. It merged in with Anatolia Minerals Development Limited in 2011 to form Alacer Gold.
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
The Ohio bioscience sector strength was ranked #4 among USA states in 2008 by Business Facilities magazine.
Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.
BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland. Therapeutic opportunities are identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products.
Martin Rogers is an Australian bioentrepreneur who has been associated since 2007 with a number of ASX-listed biotechnology companies, including Prima BioMed, which he led from 2007 to 2012.
Henri A. Termeer was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, and alumni. Termeer was "connected to 311 board members in 17 different organizations across 20 different industries" He has the legacy of being the "longest-serving CEO in the biotechnology industry.
Roivant Sciences is a healthcare company focused on applying technology to drug development. Roivant builds subsidiary biotech and healthcare technology companies. Roivant was founded by Vivek Ramaswamy in 2014.
Tattarang is an Australian private investment company owned by Andrew Forrest and his family. Tattarang invests in a diverse range of businesses across agri-food, energy, health technology, property, resources, and lifestyle. The group is made up of six business divisions: Fiveight, Harvest Road, Squadron Energy, Tenmile, Wyloo Metals and Z1Z.
References
- ↑ Thomson, James (18 July 2010). "Medical company backed by mining billionaire Andrew Forrest launches biotech investment push". SmartCompany. Retrieved 14 March 2023.
- ↑ Greenblat, Eli (18 July 2010). "Mining magnate invests in biotech". The Sydney Morning Herald. Retrieved 15 March 2023.
- 1 2 Evans, Nick (15 February 2011). "Forrest biotech company to list". PerthNow. Retrieved 15 March 2023.
- ↑ Evans, Nick (31 May 2011). "BioMD's Allied takeover wrapping up soon". PerthNow. Retrieved 15 March 2023.
- ↑ Stafford, Patrick (20 June 2011). "Andrew Forrest-backed biotech lists on ASX". SmartCompany. Archived from the original on 24 June 2011. Retrieved 15 March 2023.
- ↑ "bioMD Limited Makes Offer for Unlisted Allied Medical to Create Diversified Healthcare Group" (Press release). BioSpace. 15 February 2011. Retrieved 16 March 2023.
- 1 2 Drummond, Cameron (12 December 2013). "Biotech company buys manufacturing facility". Business News. Retrieved 15 March 2023.
- ↑ Smith, Sean (21 November 2013). "Allied rebrands as Admedus". The West Australian. Retrieved 15 March 2023.
- 1 2 "Admedus sells its CardioCel and VascuCel patch business for $A36.2m". Australian Manufacturing. 16 October 2019. Retrieved 15 March 2023.
- ↑ Ford, Omar (14 October 2019). "Admedus Turns Attention to TAVR Program". mddionline.com. Retrieved 15 March 2023.
- ↑ "Admedus Changes Name to Anteris Technologies Ltd" (Press release). GlobalNewswire. 1 June 2020. Retrieved 16 March 2023.